Related Experiment Video

Updated: May 2, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

9.7K

ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics

Carlos L Arteaga1, Jeffrey A Engelman2

  • 1Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.

Cancer Cell
|March 22, 2014
PubMed

Insights

Targeting ERBB receptors has advanced cancer therapy, but resistance mechanisms necessitate further research. This perspective reviews current strategies and future opportunities for improved cancer treatment outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Epidermal Growth Factor Receptor (EGFR) family, known as ERBB receptors, are implicated in human cancer pathogenesis.
  • Decades of research have elucidated the critical role of aberrant ERBB signaling in cancer development and progression.
  • Numerous cancer-associated genetic alterations within ERBB receptors have been identified.

Purpose of the Study:

  • To review current paradigms in targeting ERBB receptors with cancer therapeutics.
  • To discuss the mechanisms of action and resistance associated with ERBB-targeted drugs.
  • To identify future challenges and opportunities in ERBB-targeted cancer therapy.

Main Methods:

  • Literature review of existing research on ERBB receptors and cancer therapeutics.
  • Analysis of current strategies for targeting ERBB receptors.
  • Discussion of mechanisms of drug action and resistance.

Main Results:

  • Targeting ERBB receptors has led to mechanism-based therapies that have improved outcomes for many cancer patients.
  • Understanding of ERBB receptor biology and its role in cancer has substantially advanced.
  • Current ERBB-targeting strategies still face limitations.

Conclusions:

  • ERBB receptor-targeted therapies represent a significant advancement in cancer treatment.
  • Further research is crucial to overcome resistance mechanisms and improve therapeutic efficacy.
  • Continued collaboration between basic scientists and clinical investigators is essential for future breakthroughs in ERBB-targeted oncology.

More Related Videos

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.3K
Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

7.1K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

6.1K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.1K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.4K